* Roche receives 510(K) clearance from FDA for Treponema
Pallidum assay to aid Clinicians in the diagnosis of Syphilis
infection
Source text for Eikon:
Further company coverage:
The post BRIEF-Roche receives 510(K) clearance from FDA for treponema pallidum assay appeared first on NASDAQ.